Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Longping Tse and Ralph Baric.
Longping Tse
Connection Strength
2.076
Ralph Baric
  1. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses. Front Microbiol. 2020; 11:658.
    View in: PubMed
    Score: 0.879
  2. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science. 2020 12 18; 370(6523):1464-1468.
    View in: PubMed
    Score: 0.228
  3. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell. 2020 11 12; 183(4):1070-1085.e12.
    View in: PubMed
    Score: 0.226
  4. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020 07 23; 182(2):429-446.e14.
    View in: PubMed
    Score: 0.221
  5. ß-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells. J Infect Dis. 2021 08 02; 224(3):415-419.
    View in: PubMed
    Score: 0.060
  6. Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays. J Clin Microbiol. 2021 09 20; 59(10):e0052721.
    View in: PubMed
    Score: 0.060
  7. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 08 05; 184(16):4203-4219.e32.
    View in: PubMed
    Score: 0.059
  8. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature. 2021 06; 594(7864):553-559.
    View in: PubMed
    Score: 0.059
  9. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms. ACS Omega. 2021 Mar 23; 6(11):7454-7468.
    View in: PubMed
    Score: 0.058
  10. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science. 2021 02 19; 371(6531):823-829.
    View in: PubMed
    Score: 0.058
  11. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2. Cell. 2020 11 25; 183(5):1367-1382.e17.
    View in: PubMed
    Score: 0.057
  12. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science. 2020 08 07; 369(6504):731-736.
    View in: PubMed
    Score: 0.055
  13. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci Immunol. 2020 06 11; 5(48).
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.